IDEAYA Biosciences Q4 Earnings Report: What Investors Need to Know
IDEAYA Biosciences IDYA | 31.72 | -1.95% |
The earnings results for IDEAYA Biosciences (NASDAQ:IDYA) for Q4 were made public on Tuesday, February 17, 2026 at 06:00 AM.
Here's a comprehensive overview of the announcement.
Earnings
IDEAYA Biosciences beat estimated earnings by 4.08%, reporting an EPS of $-0.94 versus an estimate of $-0.98.
Revenue was up $3.88 million from the same period last year.
Historical Earnings Summary
In the previous quarter, the company beat on EPS by $1.88, resulting in a 2.69% drop change in the share price the following day.
Here's a look at IDEAYA Biosciences's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.55 | -0.82 | -0.69 | -0.61 |
| EPS Actual | 1.33 | -0.88 | -0.82 | -1.49 |
| Revenue Estimate | 87.67M | 4.48M | 2.33M | 4.54M |
| Revenue Actual | 207.83M | 0 | 0 | 7.00M |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for IDEAYA Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.